The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line
Kanbur, Ertan, Seker, Semih, Budak, Ferah, Yerlikaya, Azmi
Published in European journal of biology (01.06.2023)
Published in European journal of biology (01.06.2023)
Get full text
Journal Article
Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa
Zeren, Sezgin, Seker, Semih, Akgün, Gizem Akkaş, Okur, Emrah, Yerlikaya, Azmi
Published in Medical oncology (Northwood, London, England) (14.09.2023)
Published in Medical oncology (Northwood, London, England) (14.09.2023)
Get full text
Journal Article
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
Yerlikaya, Azmi, Okur, Emrah, Eker, Semih, Erin, Nuray
Published in Molecular medicine reports (05.02.2010)
Published in Molecular medicine reports (05.02.2010)
Get full text
Journal Article